HIGHLIGHTS
- who: Sanghoo Lee et al. from the Center for Companion Biomarker, Seoul Clinical Laboratories Healthcare Inc have published the Article: Genetic Variants Associated with Elevated Plasma Ceramides in Individuals with Metabolic Syndrome, in the Journal: Genes 2022, 13, 1497. of 12/07/2022
- what: All clinical indicators except for total cholesterol showed statistically significant differences between MetS group and healthy control (p and amp;lt; 5.0 × 10- 2 ), suggesting that the subjects with MetS who participated in this study have distinct metabolic disorders compared to the controls. This study evaluated plasma ceramide concentrations as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.